English
Проблемы кардиоиммунологии в клинике внутренних болезней
DOI: https://dx.doi.org/10.18565/therapy.2025.1.116-124
В.И. Мазуров, В.В. Тыренко, В.В. Вахлевский
1) ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России, г. Санкт-Петербург; 2) ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» Министерства обороны Российской Федерации, г. Санкт-Петербург
Литература
1. Lower R. Tractatus de corde: Item de motu & colore sanguinis et chyli in eum transitu. 1st ed. Jacobi Alleftry. 1669. 2. Waliany S., Lee D., Witteles R.M. et al. Immune checkpoint inhibitor cardiotoxicity: Understanding basic mechanisms and clinical characteristics and finding a cure. Annu Rev Pharmacol Toxicol. 2021; 61: 113–34. https://doi.org/10.1146/annurev-pharmtox-010919-023451. PMID: 32776859. 3. Ammirati E., Frigerio M., Adler E.D. et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: An expert consensus document. Circ Heart Fail. 2020; 13(11): e007405. https://doi.org/10.1161/circheartfailure.120.007405. PMID: 33176455. PMCID: PMC7673642. 4. Atri D., Siddiqi H.K., Lang J.P. et al. COVID-19 for the cardiologist: Basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies. JACC Basic Transl Sci. 2020; 5(5): 518–36. https://doi.org/10.1016/j.jacbts.2020.04.002. PMID: 32292848. PMCID: PMC7151394. 5. Levine B., Kalman J., Mayer L. et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990; 323(4): 236–41. https://doi.org/10.1056/nejm199007263230405. PMID: 2195340. 6. Adamo L., Rocha-Resende C., Prabhu S.D., Mann D.L. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020; 17(5): 269–85. https://doi.org/10.1038/s41569-019-0315-x. PMID: 31969688. 7. Tschope C., Ammirati E., Bozkurt B. et al. Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. Nat Rev Cardiol. 2020; 18(3): 169–93. https://doi.org/10.1038/s41569-020-00435-x. PMID: 33046850. PMCID: PMC7548534. 8. Herskowitz A., Choi S., Ansari A.A., Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995; 146(2): 419–28. PMID: 7856752. PMCID: PMC1869839. 9. Kapadia S.R., Oral H., Lee J. et al. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ Res. 1997; 81(2): 187–95. https://doi.org/10.1161/01.res.81.2.187. PMID: 9242179. 10. Frantz S., Kobzik L., Kim Y.D. et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 1999; 104(3): 271–80. https://doi.org/10.1172/jci6709. PMID: 10430608. PMCID: PMC408420. 11. Mann D.L. The emerging role of innate immunity in the heart and vascular system: For whom the cell tolls. Circ Res. 2011; 108(9): 1133–45. https://doi.org/10.1161/circresaha.110.226936. PMID: 21527743. PMCID: PMC3084988. 12. Mackey D., McFall A.J. MAMPs and MIMPs: Proposed classifications for inducers of innate immunity. Mol Microbiol. 2006; 61(6): 1365–71. https://doi.org/10.1111/j.1365-2958.2006.05311.x. PMID: 16899081. 13. Zhang W., Lavine K.J., Epelman S. et al. Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo. J Am Heart Assoc. 2015; 4(6): e001993. https://doi.org/10.1161/jaha.115.001993. PMID: 26037082. PMCID: PMC4599537. 14. Frantz S., Falcao-Pires I., Balligand J.-L. et al. The innate immune system in chronic cardiomyopathy: A European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC. Eur J Heart Fail. 2018; 20(3): 445–59. https://doi.org/10.1002/ejhf.1138. PMID: 29333691. PMCID: PMC5993315. 15. Toldo S., Abbate A. The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol. 2018; 15(4): 203–14. https://doi.org/10.1038/nrcardio.2017.161. PMID: 29143812. 16. Prabhu S.D., Frangogiannis N.G. The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis. Circ Res. 2016; 119(1): 91–112. https://doi.org/10.1161/circresaha.116.303577. PMID: 27340270. PMCID: PMC4922528. 17. Swirski F.K., Nahrendorf M. Cardioimmunology: The immune system in cardiac homeostasis and disease. Nat Rev Immunol. 2018; 18(12): 733–44. https://doi.org/10.1038/s41577-018-0065-8. PMID: 30228378. 18. Torre-Amione G., Kapadia S., Lee J. et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996; 93(4): 704–11. https://doi.org/10.1161/01.cir.93.4.704. PMID: 8640999. 19. Bartekova M., Radosinska J., Jelemensky M., Dhalla N.S. Role of cytokines and inflammation in heart function during health and disease. Heart Fail Rev. 2018; 23(5): 733–58. https://doi.org/10.1007/s10741-018-9716-x. PMID: 29862462. 20. Bajpai G., Schneider C., Wong N. et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med. 2018; 24(8): 1234–45. https://doi.org/10.1038/s41591-018-0059-x. PMID: 29892064. PMCID: PMC6082687. 21. Koenig A.L., Shchukina I., Amrute J. et al. Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure. Nat Cardiovasc Res. 2022; 1(3): 263–80. https://doi.org/10.1038/s44161-022-00028-6. PMID: 35959412. PMCID: PMC9364913. 22. Noutsias M., Pauschinger M., Schultheiss H., K hl U. Phenotypic characterization of infiltrates in dilated cardiomyopathy – diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Med Sci Monit. 2002; 8(7): CR478–87. PMID: 12118194. 23. Parrillo J.E., Cunnion R.E., Epstein S.E. et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med. 1989; 321(16): 1061–68. https://doi.org/10.1056/nejm198910193211601. PMID: 2677721. 24. Dick S.A., Epelman S. Chronic heart failure and inflammation: What do we really know? Circ Res. 2016; 119(1): 159–76. https://doi.org/10.1161/circresaha.116.308030. PMID: 27340274. 25. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454(7203): 428–35. https://doi.org/10.1038/nature07201. PMID: 18650913. 26. Hayashi T., Tiwary S.K., Lavine K.J. et al. The programmed death 1 signaling axis modulates inflammation and left ventricular structure and function in a stress-induced cardiomyopathy model. JACC Basic Transl Sci. 2022; 7(11): 1120–39. https://doi.org/10.1016/j.jacbts.2022.05.006. PMID: 36687266. PMCID: PMC9849278. 27. Hayashi T., Lim K.R.Q., Kovacs A., Mann D.L. Recurrent adrenergic stress provokes persistent myocarditis in PD-1-deficient mice. JACC Basic Transl Sci. 2023; 8(12): 1503–17. https://doi.org/10.1016/j.jacbts.2023.07.012. PMID: 38205352. PMCID: PMC10774592. 28. Palaskas N.L., Segura A., Lelenwa L. et al. Immune checkpoint inhibitor myocarditis: Elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail. 2021; 23(10): 1725–35. https://doi.org/10.1002/ejhf.2265. PMID: 34114291. 29. Stafford N., Assrafally F., Prehar S. et al. Signaling via the interleukin-10 receptor attenuates cardiac hypertrophy in mice during pressure overload, but not isoproterenol infusion. Front Pharmacol. 2020; 11: 559220. https://doi.org/10.3389/fphar.2020.559220. PMID: 33192505. PMCID: PMC7662881. 30. Verma S.K., Krishnamurthy P., Barefield D. et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB. Circulation. 2012; 126(4): 418–29. https://doi.org/10.1161/circulationaha.112.112185. PMID: 22705886. PMCID: PMC3422741. 31. Frustaci A., Russo M.A., Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: The TIMIC study. Eur Heart J. 2009; 30(16): 1995–2002. https://doi.org/10.1093/eurheartj/ehp249. PMID: 19556262. 32. Deswal A., Bozkurt B., Seta Y. et al. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999; 99(25): 3224–26. https://doi.org/10.1161/01.cir.99.25.3224. PMID: 10385494. 33. Bozkurt B., Torre-Amione G., Warren M.S. et al. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001; 103(8): 1044–47. https://doi.org/10.1161/01.cir.103.8.1044. PMID: 11222463. 34. Nast A., Smith C., Spuls P.I. et al. EuroGuiDerm guideline on the systemic treatment of Psoriasis vulgaris – part 2: Specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021; 35(2): 281–317. https://doi.org/10.1111/jdv.16926. PMID: 33547728. 35. Kleveland O., Kunszt G., Bratlie M. et al. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: A double-blind, randomized, placebo-controlled phase 2 trial. Eur Heart J. 2016; 37(30): 2406–13. https://doi.org/10.1093/eurheartj/ehw171. PMID: 27161611. 36. Mann D.L. Innate immunity and the failing heart: The cytokine hypothesis revisited. Circ Res. 2015; 116(7): 1254–68. https://doi.org/10.1161/circresaha.116.302317. PMID: 25814686. PMCID: PMC4380242. 37. Gullestad L., Aass H., Fjeld J.G. et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation. 2001; 103(2): 220–25. https://doi.org/10.1161/01.cir.103.2.220. PMID: 11208680. 38. Moreira D.M., Vieira J.L., Gottschall C.A.M. The effects of METhotrexate therapy on the physical capacity of patients with ISchemic heart failure: A randomized double-blind, placebo-controlled trial (METIS trial). J Card Fail. 2009; 15(10): 828–34. https://doi.org/10.1016/j.cardfail.2009.06.439. PMID: 19944358. 39. McNamara D.M., Holubkov R., Starling R.C. et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001; 103(18): 2254–59. https://doi.org/10.1161/01.cir.103.18.2254. PMID: 11342473. 40. Fadok V.A., Bratton D.L., Konowal A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998; 101(4): 890–98. https://doi.org/10.1172/jci1112. PMID: 9466984. PMCID: PMC508637. 41. Torre-Amione G., Sestier F., Radovancevic B., Young J. Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: Results of a randomized, controlled, phase II trial. J Am Coll Cardiol. 2004; 44(6): 1181–86. https://doi.org/10.1016/j.jacc.2004.06.047. PMID: 15364317. 42. Torre-Amione G., Anker S.D., Bourge R.C. et al; Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy Investigators. Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): A placebo-controlled randomised trial. Lancet. 2008; 371(9608): 228–36. https://doi.org/10.1016/S0140-6736(08)60134-8. PMID: 18207018.
Об авторах / Для корреспонденции
Вадим Иванович Мазуров, д. м. н., профессор, академик РАН, вице-президент РНМОТ, главный научный консультант, директор Научно-исследовательского института ревматологии, заведующий кафедрой терапии, ревматологии, экспертизы временной нетрудоспособности и качества медицинской помощи с курсом гематологии и трансфузиологии им. Э.Э. Эйхвальда ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России, главный внештатный специалист – ревматолог Комитета по здравоохранению Правительства Санкт-Петербурга, заслуженный деятель науки РФ. Адрес: 191015, г. Санкт-Петербург, ул. Кирочная, д. 41.
E-mail: maz.nwgmu@yandex.ru
ORCID: https://orcid.org/0000-0002-0797-2051. Scopus Author ID: 16936315400. eLibrary SPIN: 6823-5482
Вадим Витальевич Тыренко, д. м. н., профессор, начальник кафедры факультетской терапии ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» Министерства обороны Российской Федерации. Адрес: 194044, г. Санкт-Петербург, ул. Академика Лебедева, д. 6Ж.
ORCID: https://orcid.org/0000-0002-0470-1109. eLibrary SPIN: 3022-5038
Виталий Васильевич Вахлевский, к. м. н., начальник терапевтического отделения клиники кафедры факультетской терапии ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» Министерства обороны Российской Федерации. Адрес: 194044, г. Санкт-Петербург, ул. Академика Лебедева, д. 6Ж.
ORCID: https://orcid.org/0000-0001-5699-2414. eLibrary SPIN: 4796-5338
Похожие статьи
